| 1 | [SID92763369] | Active | Potency | 0.0116 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.0116 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 2 | [SID92763369] | Active | Potency | 0.0116 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.0116 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID92763369] | Active | Potency | 0.0116 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.0116 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID92763369] | Active | Potency | 0.0164 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.0164 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID92763369] | Active | Potency | 0.0164 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.0164 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID92763369] | Active | Potency | 0.0164 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.0164 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID92763369] | Active | Potency | 0.0366 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.0366 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID92763369] | Active | Potency | 0.2593 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.2593 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 9 | [SID92763369] | Active | Potency | 0.2593 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.2593 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 10 | [SID92763369] | Active | Potency | 0.2593 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | Potency | 0.2593 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 11 | [SID92763369] | Active | AC50 | 0.26 | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity [AID687027, Type: confirmatory] | PAX8 [Homo sapiens] [gi:998701] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | AC50 | 0.26 [uM] | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity | | AID | 687027 | | BioAssay type | confirmatory | | Target | PAX8 [Homo sapiens] [gi:998701] | | PubMed | | | Data Table |  |
|
| 12 | [SID92763369] | Active | AC50 | 0.26 | CEM21 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7013-03_Inhibitor_Dose_CherryPick_Activity [AID652042, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | AC50 | 0.26 [uM] | | BioAssay | CEM21 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7013-03_Inhibitor_Dose_CherryPick_Activity | | AID | 652042 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID92763369] | Active | AC50 | 0.322 | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_Dose_CherryPick_Activity [AID652057, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | AC50 | 0.322 [uM] | | BioAssay | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_Dose_CherryPick_Activity | | AID | 652057 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID92763369] | Active | AC50 | 2.04 | Cell fusion assay for clade C HIV-1ZM109 Env Measured in Cell-Based System Using Plate Reader - 7013-05_Inhibitor_Dose_CherryPick_Activity [AID652058, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | AC50 | 2.04 [uM] | | BioAssay | Cell fusion assay for clade C HIV-1ZM109 Env Measured in Cell-Based System Using Plate Reader - 7013-05_Inhibitor_Dose_CherryPick_Activity | | AID | 652058 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID92763369] | Active | AC50 | 3.45 | HIV-1 Cell Fusion assay for clade B Env AD8 Measured in Cell-Based System Using Plate Reader - 7013-04_Inhibitor_Dose_CherryPick_Activity [AID652062, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | AC50 | 3.45 [uM] | | BioAssay | HIV-1 Cell Fusion assay for clade B Env AD8 Measured in Cell-Based System Using Plate Reader - 7013-04_Inhibitor_Dose_CherryPick_Activity | | AID | 652062 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID92763369] | Active | AC50 | 3.78 | Control Cell Fusion Counterscreen Assay Measured in Cell-Based System Using Plate Reader - 7013-02_Inhibitor_Dose_CherryPick_Activity [AID652040, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | AC50 | 3.78 [uM] | | BioAssay | Control Cell Fusion Counterscreen Assay Measured in Cell-Based System Using Plate Reader - 7013-02_Inhibitor_Dose_CherryPick_Activity | | AID | 652040 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID92763369] | Active | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | PAX8 [Homo sapiens] [gi:998701] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | PAX8 [Homo sapiens] [gi:998701] | | PubMed | | | Data Table |  |
|
| 18 | [SID92763369] | Active | | | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity [AID651658, Type: screening] | FGF22 gene product [Homo sapiens] [gi:10190672] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651658 | | BioAssay type | screening | | Target | FGF22 gene product [Homo sapiens] [gi:10190672] | | PubMed | | | Data Table |  |
|
| 19 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 20 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 21 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 22 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 23 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 24 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 25 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID652008, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 652008 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 26 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID652008, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 652008 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 27 | [SID92763369] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 28 | [SID92763369] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 29 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588792, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588792 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 30 | [SID92763369] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 31 | [SID92763369] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 32 | [SID92763369] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 33 | [SID92763369] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID652245, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 652245 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 34 | [SID92763369] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID652245, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 652245 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 35 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). [AID588820, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). | | AID | 588820 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 36 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). [AID588820, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). | | AID | 588820 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 37 | [SID92763369] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 38 | [SID92763369] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 39 | [SID92763369] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 40 | [SID92763369] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 41 | [SID92763369] | Active | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts [AID652141, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts | | AID | 652141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID92763369] | Active | | | Counterscreen for antagonists of COUP-TFII (NR2F2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID687007, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Counterscreen for antagonists of COUP-TFII (NR2F2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 687007 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID92763369] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 44 | [SID92763369] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 45 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 46 | [SID92763369] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 47 | [SID92763369] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 48 | [SID92763369] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 49 | [SID92763369] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 50 | [SID92763369] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 92763369 | | CID | 373978 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|